Labiotech.eu

france innovators under 35 mit tech review millidrop glowee biotech

Best in Biotech 18 Apr 2016

Who are France’s Young Innovators in Biotech and Medicine this year?

The MIT Technology Review has released it’s next generation of best and brightest in French Tech. This also includes a surprising number of Biotech entrepreneurs… The 2016 cohort of French innovators under 35 will now join the ranks of many high risers in the Biotech industry, many of which have gone on to secure funding and […]

April 18, 2016 - 4 minutesmins - By Dani Bancroft

oxford biotherapeutics drug cancer boehringer

News and Trends 18 Apr 2016

UK Drug Discovery sells Cancer Target to German Pharma

Boehringer Ingelheim has bought exclusive rights to an oncology target discovered by Oxford BioTherapeutics and its proteomic database. Oxford BioTherapeutics is a Biotech in Milton Park (near Oxford, UK), developing immunotherapies for cancer with antibody-drug conjugates (ADC) – a strategy to combine the specificity of antibodies to a toxic agent that can be delivered to a cancerous cell. […]

April 18, 2016 - 2 minutesmins - By Denise Neves Gameiro

News and Trends 18 Apr 2016

Very promising Results for Resistant Lung Cancer

Ariad has presented updated results of an ongoing phase I/II trial for lung cancer, scoring 100% in one-year overall survival. Ariad Pharmaceuticals is developing small molecules to treat difficult cancers, using computational and structural biology research. It is based in Cambridge (US) and Lausanne (Switzerland). One of the hard-to-treat cancers that Ariad is targeting is […]

April 18, 2016 - 3 minutesmins - By Denise Neves Gameiro

Gensight gene therapy biotech bernard gilly labiotech

News and Trends 18 Apr 2016

ITW: This Biotech Startup wants to fix Youth Blindness with a Gene Therapy

While on a stop in New York, I had a chance to chat with Bernard Gilly, the founder and CEO of the Paris biotech GenSight. I wanted to learn more about the company, which is one of the only examples in the World using Gene therapy to treat specific and rare types of blindness. GenSight […]

April 18, 2016 - 6 minutesmins - By Philip Hemme

bioart thomas feuerstein bioreactors sculptures

News and Trends 17 Apr 2016

BioArt : Feeding the Mind with Thomas Feuerstein’s Living Machines and Green Organs

Thomas Feuerstein is an Austrian BioArtist who sculptures with living organisms and Biotechnology lab equipment – which challenges the mentality of hardcore Green science. Based in Innsbruck, Thomas originally studied Art History and Philosophy. His works started dwelling on Biotech during the 90’s, from when he was part of the Bibliophy project, which ran from 1995 to 2002. This aimed to discuss ideas […]

April 17, 2016 - 4 minutesmins - By Denise Neves Gameiro

News and Trends 16 Apr 2016

What happened this week? 18 Top-VCs, CAR-T and CRISPR

1. 18 of the Best European VCs for Biotech in 2016 2. How CAR-T Cells Kill Cancer: Pictures start Moving 3. Meet the CEO who wants to transform Pretty Corals into therapies for Cancer 4. It’s World Parkinson’s Disease Day! #EndParkinsons 5. Modern Biotechnology is now 40 – Happy Birthday! From Inside Labiotech: Secret unveiled: CRISPR […]

April 16, 2016 - 1 minutemin - By Philip Hemme

geneuro euronext multiple sclerosis biotech

News and Trends 16 Apr 2016

First Euronext Biotech IPO of 2016 is Swiss, and for Multiple Sclerosis!

We last wrote about GeNeuro in January, when they announced the launch of an IPO for their Multiple Sclerosis phase IIb trial. Now, as of yesterday they are listed on the Euronext Paris market. GeNeuro (in Geneva) is developing therapies and diagnostic tools for diseases associated with the expression of the human endogenous retrovirus MSRV, such […]

April 16, 2016 - 2 minutesmins - By Dani Bancroft

nsclc mirati qiagen cancer oncology lung mrna

News and Trends 15 Apr 2016

Qiagen Deal to make Genetic Diagnostic Test for Lung Cancer

Qiagen and Mirati will collaborate on the development of a companion diagnostic for a specific type of form of Non-Small Lung Cancer – supporting Mirati’s new therapy. With its operational headquarters near Düsseldorf (Germany), Qiagen is an EU giant in Molecular Diagnostics, and even stepped into the NGS battleground after the acquisition of an important supplier. Qiagen is now entering […]

April 15, 2016 - 3 minutesmins - By Denise Neves Gameiro

Vibiosphen biotech infectious disease pierre fabre

News and Trends 15 Apr 2016

Pierre Fabre partners for Open Innovation in Infectious Disease

Pierre Fabre has a new partnership for its Open Innovation programme based on an extensive plant library. It will now count with VibioSphen to develop new phyto-chemicals to fight infectious diseases. Pierre Fabre is the 3rd largest Pharma in France, employing over 10,000 people and generating revenues of over €2Bn. Lately, this mid-sized company made efforts […]

April 15, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 15 Apr 2016

Biotech of the Week: ThromboGenics & Therapies against Eye Disease

This week, we say Auf wiedersehen to Vienna and move on to the North west. Leuven, the capital city of the Flemish Brabant province in Belgium, fairly close to the country’s capital Brussels. And it is also where ThromboGenics, our Biotech of The Week is located. City: Leuven (Belgium) Founded: 1998 Employees: 85 (including US) Market cap: […]

April 15, 2016 - 2 minutesmins - By Joachim Eeckhout

labiotech thomas taapken epicolon biotech epigenomics cancer philipp hemme berlin

News and Trends 14 Apr 2016

We met the Biotech with the First & Only US Approved Blood Test for Colorectal Cancer

Colorectal cancer is the second biggest cancer killer in the US, but Epigenomics could dramatically improve this sad figure. A problem Berlin-based Epigenomics want to solve and just got a significant milestone: an FDA approval for commercialisation. I met with Thomas Taapken, the CEO of the company, in his office in Berlin, a nice historical building with 4 meters ceiling […]

April 14, 2016 - 6 minutesmins - By Philip Hemme

evolva us navy composite material synbio

News and Trends 14 Apr 2016

European Biotech teams up with US Navy to engineer Military Materials

Evolva will join the US Navy to make new materials with its biosynthetic molecules – which could make it into aircrafts and ships. Evolva is a Synthetic biology Biotech headquartered near Basel (Switzerland), but with offices and R&D also in Denmark. It has developed its yeast platform to produce high-value chemicals via fermentation. So far, […]

April 14, 2016 - 3 minutesmins - By Denise Neves Gameiro

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Who are France’s Young Innovators in Biotech and Medicine this year?

UK Drug Discovery sells Cancer Target to German Pharma

Very promising Results for Resistant Lung Cancer

ITW: This Biotech Startup wants to fix Youth Blindness with a Gene Therapy

BioArt : Feeding the Mind with Thomas Feuerstein’s Living Machines and Green Organs

What happened this week? 18 Top-VCs, CAR-T and CRISPR

First Euronext Biotech IPO of 2016 is Swiss, and for Multiple Sclerosis!

Qiagen Deal to make Genetic Diagnostic Test for Lung Cancer

Pierre Fabre partners for Open Innovation in Infectious Disease

Biotech of the Week: ThromboGenics & Therapies against Eye Disease

We met the Biotech with the First & Only US Approved Blood Test for Colorectal Cancer

European Biotech teams up with US Navy to engineer Military Materials

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!